Transfusion-acquired cytomegalovirus (CMV) infections should be prevented in seronegative immunocompromised patients by providing blood products from donors who are also seronegative. Latex agglutination was investigated as a simple and rapid method for detecting antibody against CMV. Latex beads were coated with CMV antigen, incubated for 8 min at room temperature with 25 ,uI of sera, and examined for agglutination. The sensitivity and specificity of latex agglutination was compared with that of indirect hemagglutination (IHA, Cetus Corp., Emeryville, Calif.) Because of the recent observations that immunocompromised patients lacking antibody against cytomegalovirus (CMV) (seronegative) are at risk for acquiring CMV from blood or blood products from blood donors with serological evidence of a prior CMV infection (seropositive), the ability to detect immunoglobulin G antibodies against CMV is important for many diagnostic and blood bank laboratories (1). The ability of a variety of antigens and antibodies to bind to latex particles has resulted in many simple and rapid diagnostic tests, and we have evaluated latex agglutination for detection of antibodies against CMV, both in blood donors and recipients. We compared latex agglutination to two effective methods (indirect hemagglutination [IHA] 
Because of the recent observations that immunocompromised patients lacking antibody against cytomegalovirus (CMV) (seronegative) are at risk for acquiring CMV from blood or blood products from blood donors with serological evidence of a prior CMV infection (seropositive), the ability to detect immunoglobulin G antibodies against CMV is important for many diagnostic and blood bank laboratories (1) . The ability of a variety of antigens and antibodies to bind to latex particles has resulted in many simple and rapid diagnostic tests, and we have evaluated latex agglutination for detection of antibodies against CMV, both in blood donors and recipients. We compared latex agglutination to two effective methods (indirect hemagglutination [IHA] and enzyme immunoassay [EIA] ) for identifying seropositive blood donors (2, 3, 8 (Table 2) ; however, IHA was significantly less specific than either EIA or latex agglutination, with a false-positive rate of 9.9%o (test statistic = 34, 1 df, P <0.0001).
To evaluate both the feasibility of using plasma and the reproducibility of latex agglutination, 255 serum-plasma pairs were assayed for antibody against CMV by latex agglutination ( Table 3) . None of the three anticoagulants gave false-negative or false-positive results. For all positive sera tested, the plasma titer was either identical to the serum titer or differed by only one twofold dilution (Table 3) . Of the three anticoagulants, CPDA-1 gave the greatest percentage of twofold dilution discrepancies between serum and plasma samples. Of 49 samples showing no agglutination in undiluted sera, 41 agglutinated with undiluted CPDA-1 anticoagulated plasma, and of these one had a titer of 1:2. Of 48 sera with a latex agglutination titer of -1:4, the corresponding CPDA-1 plasma titer differed by a twofold dilution in 19 cases. Of these, the CPDA-1 plasma titer was twofold higher than the serum titer in 13 instances and twofold lower than the serum titer in six instances. This was unexpected because of the dilution effect of the CPDA-1 anticoagulant (62.5 ml of a 500-ml unit of blood is anticoagulant). If the average unit is 60% plasma (hematocrit of 40), then the plasma was diluted 20% by the anticoagulant. These results showed that latex agglutination was both reproducible and suitable for use with plasma but that undiluted CPDA-1 probably caused nonspecific latex agglutination.
Latex agglutination was also used quantitatively to detect antibody against CMV. Latex agglutination detected fourfold or greater rises in antibody against CMV in six patients with posttransfusion CMV infections (Table 4) . For these high-titer (>1:64) sera, there was a significant correlation between EIA (antibody units) and latex agglutination (titers) (r = 0.87). Figure 1 shows a significant correlation between antibody units as measured by EIA and the latex agglutination titers (r = 0.75) for 35 low-titer (<1:128) sera. Because of the twofold dilutions used in the latex agglutination test, a perfect correlation (r = 1) is not possible. However, if only one of the two tests was performed, approximate ranges of either latex agglutination titers or EIA antibody units can be predicted.
DISCUSSION
Although there are numerous methods for measuring antibodies against CMV, two methods (EIA and IHA) have proven efficacy in screening blood donors to aid in the prevention of posttransfusion CMV infections (2, 3, 8) . Our results indicate that latex agglutination compares favorably (7, 8) .
We interpreted a latex agglutination titer of 1:2 as being negative. However, too few sera with this titer were tested for a definite interpretation of the meaning of this titer. Sera with a latex agglutination titer of 1:2 may either be retested, tested by other methods, considered seropositive if screening blood donor sera, or considered seronegative if testing organ or blood recipient sera.
The major advantages of latex agglutination over other methods for measuring antibody against CMV are ease of performance and interpretation, rapidity, and inexpensive equipment. Incubation time is only 8 min. Other methods in current use, including complement fixation, IHA, EIA, solid-phase immunoassays, fluorescent immunoassays, anticomplement immunofluorescence, and passive hemagglutination, require significantly longer. In addition, methods such as EIA and solid-phase fluorescence immunoassay require either expensive fluorometers or spectrophotometers.
Detection of antibody against CMV in donor sera is currently the only proven method for the prevention of posttransfusion CMV infection in seronegative recipients. Seronegative recipients for whom the prevention of posttransfusion CMV infections should be considered include premature newborns, transplant recipients, pregnant women, and certain groups of severely immunocompro- mised patients, particularly those likely to be candidates for bone marrow transplantation (1) . Because of its excellent sensitivity and specificity, latex agglutination should be suitable for screefling both blood donors and blood recipients, and thus is an appropriate method to aid in preventing posttransfusion CMV infections. Latex agglutination results correlated well with those of EIA when used quantitatively and can also be used to diagnose posttransfusion CMV infections.
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